Compression Therapy Market (By Product: Compression Pumps, Compression Stockings, Compression Bandages, Compression Tape; By Technology: Static Compression Therapy, Dynamic Compression Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global compression therapy market size reached USD 4.58 billion in 2023 and is estimated to hit around USD 8.40 billion by 2033 with a CAGR of 6.25% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. compression therapy market size was estimated at USD 1.51 billion in 2023 and is anticipated to reach around USD 2.77 billion by 2033, poised to grow at a CAGR of 6.33% from 2024 to 2033.
North America held the largest market share of 44% in 2023 The region is observed to sustain its position in the upcoming years. The growth of the North American region is attributed to the sophisticated healthcare infrastructure, rising investments in research and development activities and rising awareness of the significance of compression therapy.
Moreover, the rising healthcare expenditure, rising, geriatric population, growing healthcare awareness, and rising prevalence of chronic disorders such as deep vein thrombosis (DVT), lymphedema, peripheral artery disease (PAD), and chronic venous disease (CVD) also promote the expansion of the market in the region.
Chronic Venous Disease (CVD) refers to the medical conditions related to or caused by veins that become diseased or abnormal. According to the report published by the National Institutes of Health (NIH) in April 2023, Varicose veins afflict more than 25 million people in the United States, and more than 6 million harbors severe venous disease, making CVD a prevalent health condition. The most common signs of CVD are telangiectases, reticular veins, varicose veins, and venous ulcerations.
In North America, the United States is observed to remain as the largest contributor to the compression therapy market due to the presence of major compression therapy product manufacturers, favorable government reimbursement policies, and increasing awareness regarding early diagnosis of venous ulcers, arthritis, and others. Moreover, the rising number of road accidents and sports injuries has resulted in the increasing adoption of compression therapy for the healing of injuries. Furthermore, companies are engaged in strategic approaches such as partnership or collaboration, acquisitions, mergers, and product launches.
Asia Pacific is expected to witness the fastest growth in the compression therapy market during the forecast period. The growth of the region is attributed to the increasing investment in the healthcare infrastructure and, robust focus on wellness resulting in rising product adoption, an increase in the number of road accidents, an increasing burden of chronic vein disorders (CVD) adult population, increasing sport injuries, rising innovation in product development, and growing geriatric and obesity population. In addition, the market has witnessed the sales of compression therapy products growing through e-commerce. Online pharmacies are leveraging on offering doorstep delivery and discounts which are quite appealing to the end-users.
The compression therapy market services associated with effective treatment to help improve blood flow in your lower legs. Such services are often associated with varicose veins and compression products and devices that provide relief to the patient. This therapy uses the technique of controlled pressure to increase blood flow in the legs which in turn helps to improve blood flow to the heart, support veins, and reduce swelling in the lower extremities.
Compression therapy involves the use of socks, stockings, and bandages which are specially designed to provide compression on legs, ankles, and feet as well as support veins to increase blood circulation in the legs. Compression therapy can treat swelling and when there is more than enough or extra fluid in the legs, compression assists the body to absorb it.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 6.25% |
Global Market Size in 2023 | USD 4.58 Billion |
Global Market Size by 2033 | USD 8.40 Billion |
U.S. Market Size in 2023 | USD 1.51 Billion |
U.S. Market Size by 2033 | USD 2.77 Billion |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product and By Technology |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: The increasing burden of sports injuries and accidents
The rising number of sports injuries and accidents is expected to fuel the growth of the compression therapy market during the forecast period. Compression therapy is increasingly becoming popular due to the rising cases of sports injuries and traffic accidents. Sports injuries and road accident victims often suffer from mild to severe injuries. Compression therapy assists in supporting veins and improves blood circulation in the legs.
In addition, football has reported the highest number of injuries, at over 1.5 million each year. 40 percent of all football injuries are sprains and strains. In addition, the increasing demand for Compression therapy is driven by the rising cases of road accidents. Such supportive factors are contributing to the market’s growth during the forecast period.
Restraint: Lack of awareness
The lack of awareness is anticipated to restrain the compression therapy market's expansion during the forecast period. Less awareness of compression therapy among people as well as regarding the benefits of compression therapy particularly in underdeveloped countries. In addition, the availability of alternative therapies may result in restricting the expansion of the market.
Opportunity: Increasing demand for advanced therapies and new product launches
The rapidly rising demand for advanced therapies along with the new product launches is projected to offer a lucrative opportunity for the growth of the compression therapy market during the forecast period. Several key market players are constantly investing in innovating advanced therapies and technologies for managing the treatment of venous diseases. The use of compression therapy can help to improve the quality of life and it is also an effective form of treatment for various medical conditions such as improving blood flow, reducing swelling in the legs, lessening the risk of blood clots, aiding in healing leg ulcers, and effective treatment for varicose veins. Additionally, the rise in new product launches is projected to create significant opportunities for the market’s growth during the forecast period.
The compression bandages segment accounted for the dominating segment in the compression therapy market share of 44% in 2023 owing to the increasing adoption for treatment of Edema, Chronic Venous Insufficiency (CVI), and Deep Vein Thrombosis (DVT). Compression bandages are mainly classified into types elastic and inelastic. Compression bandages are extensively used for the treatment of venous diseases as well as to prevent their re-occurrence during compression therapy. Compression bandages can be wrapped around a sprain or strain. The gentle pressure of the bandage helps to reduce swelling in the injured area. The aforementioned factors will accelerate the segment's growth.
The compression pumps segment is observed to witness a significant rate of growth in the compression therapy market over the forecast period. The segment is growing due to the increasing cases of lymphedema and other venous disorders. Compression pumps are advanced, user-friendly, and have adjustable pressure settings to cater to specific patient needs as per the severity of the disorder. Thereby, boosting the growth in the market.
The static technology segment held the largest share of the compression therapy market in 2023, the segment is expected to sustain the position throughout the forecast period. Static technology has convenience and user-friendly attributes. The benefits associated with static technology help in treating edema and sports-related injuries to alleviate pain. Static technology is highly preferred by physicians for treating deep vein thrombosis, lymphedema, and chronic venous insufficiency (CVI).
The dynamic technology segment is expected to grow at a significant rate in the compression therapy market during the forecast period. The growth of the segment is driven by improvements in technology. Dynamic compression therapy helps to improve performance and reduce muscle recovery time. Smart features provide real-time feedback and facilitate personalized treatment facilities, and resulting in better patient results. The rising acceptance of sophisticated healthcare solutions is projected to accelerate the segment’s growth.
Segments Covered in the Report
By Product
By Technology
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Compression Therapy Market
5.1. COVID-19 Landscape: Compression Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Compression Therapy Market, By Product
8.1. Compression Therapy Market, by Product, 2024-2033
8.1.1. Compression Pumps
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Compression Stockings
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Compression Bandages
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Compression Tape
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Compression Therapy Market, By Technology
9.1. Compression Therapy Market, by Technology, 2024-2033
9.1.1. Static Compression Therapy
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Dynamic Compression Therapy
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Compression Therapy Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Forecast, by Technology (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Forecast, by Technology (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Forecast, by Technology (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Forecast, by Technology (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Forecast, by Technology (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Forecast, by Technology (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Forecast, by Technology (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Forecast, by Technology (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Forecast, by Technology (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Forecast, by Technology (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Forecast, by Technology (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Forecast, by Technology (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Forecast, by Technology (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Forecast, by Technology (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.3.2. Market Revenue and Forecast, by Technology (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Forecast, by Technology (2021-2033)
Chapter 11. Company Profiles
11.1. Smith & Nephew PLC
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medline Industries, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Cardinal Health
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Julius Zorn GmbH
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Hartmann AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Medi GmbH & Co.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. SIGVARIS
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BSN Medical GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Convatec Group PLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Bio Compression Systems, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client